Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vascular Solutions, Inc. Reaffirms FY 2012 Guidance; Issues Q1 2012 Guidance; EPS Guidance Below Analysts' Estimates
Vascular Solutions, Inc. announced that for fiscal 2012, it continues to target net revenue of between $94 million and $96 million. continues to project net earnings to be between $0.51 to $0.55 per fully diluted share. For the first quarter of 2012, it expects net revenue of between $22.3 million and $22.7 million, net income is projected to be between $0.10 and $0.11 per diluted share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $96 million and EPS of $0.54 fiscal 2012; revenues of $23.3 million and EPS of $0.12 for the first quarter of 2012.
Latest Developments for Vascular Solutions Inc
- Vascular Solutions Inc Reaffirms FY 2013 Guidance; Issues Q2 2013 In Line With Analysts' Estimates
- Vascular Solutions Inc Issues Q1, FY 2013 Guidance In Line With Analysts' Estimates
- Vascular Solutions Inc Raises FY 2012 Revenue Guidance; Raises Low End Of Prior FY 2012 EPS Guidance; Issues Q4 2012 Guidance In Line With Analysts' Estimates
- Vascular Solutions, Inc. Raises FY 2012 Guidance; Issues Q3 2012 Guidance; Revenue Guidance Above Analysts' Estimates
Latest Key Developments in Advanced
- Covidien PLC Receives FDA 510(k) Clearance For Nellcor Pulse Oximetry Motion Claims
- Toumaz Ltd Announces Issue Of Equity In Relation To Deferred Consideration
- Natus Medical Inc Reaffirms Q2 2013 Guidance; Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance
- Japan Asia Group Ltd Sells Shares of ImageONE Co Ltd
- Share this
- Link this
- Digg this


Follow Reuters